Display options
Cite
Strickland M, Stoll EA. Metabolic Reprogramming in Glioma. Front Cell Dev Biol. 2017;5:43doi: 10.3389/fcell.2017.00043.
Strickland, M., & Stoll, E. A. (2017). Metabolic Reprogramming in Glioma. Frontiers in cell and developmental biology, 543. https://doi.org/10.3389/fcell.2017.00043
Strickland, Marie, and Stoll, Elizabeth A. "Metabolic Reprogramming in Glioma." Frontiers in cell and developmental biology vol. 5 (2017): 43. doi: https://doi.org/10.3389/fcell.2017.00043
Strickland M, Stoll EA. Metabolic Reprogramming in Glioma. Front Cell Dev Biol. 2017 Apr 26;5:43. doi: 10.3389/fcell.2017.00043. eCollection 2017. PMID: 28491867; PMCID: PMC5405080.
Copy Download .nbib Format: NLM
Share it on

Front Cell Dev Biol. 2017 Apr 26;5:43. doi: 10.3389/fcell.2017.00043. eCollection 2017.

Metabolic Reprogramming in Glioma.

Frontiers in cell and developmental biology

Marie Strickland, Elizabeth A Stoll

Affiliations

  1. Institute of Neuroscience, Newcastle UniversityNewcastle upon Tyne, UK.

PMID: 28491867 PMCID: PMC5405080 DOI: 10.3389/fcell.2017.00043

Abstract

Many cancers have long been thought to primarily metabolize glucose for energy production-a phenomenon known as the Warburg Effect, after the classic studies of Otto Warburg in the early twentieth century. Yet cancer cells also utilize other substrates, such as amino acids and fatty acids, to produce raw materials for cellular maintenance and energetic currency to accomplish cellular tasks. The contribution of these substrates is increasingly appreciated in the context of glioma, the most common form of malignant brain tumor. Multiple catabolic pathways are used for energy production within glioma cells, and are linked in many ways to anabolic pathways supporting cellular function. For example: glycolysis both supports energy production and provides carbon skeletons for the synthesis of nucleic acids; meanwhile fatty acids are used both as energetic substrates and as raw materials for lipid membranes. Furthermore, bio-energetic pathways are connected to pro-oncogenic signaling within glioma cells. For example: AMPK signaling links catabolism with cell cycle progression; mTOR signaling contributes to metabolic flexibility and cancer cell survival; the electron transport chain produces ATP and reactive oxygen species (ROS) which act as signaling molecules; Hypoxia Inducible Factors (HIFs) mediate interactions with cells and vasculature within the tumor environment. Mutations in the tumor suppressor p53, and the tricarboxylic acid cycle enzymes Isocitrate Dehydrogenase 1 and 2 have been implicated in oncogenic signaling as well as establishing metabolic phenotypes in genetically-defined subsets of malignant glioma. These pathways critically contribute to tumor biology. The aim of this review is two-fold. Firstly, we present the current state of knowledge regarding the metabolic strategies employed by malignant glioma cells, including aerobic glycolysis; the pentose phosphate pathway; one-carbon metabolism; the tricarboxylic acid cycle, which is central to amino acid metabolism; oxidative phosphorylation; and fatty acid metabolism, which significantly contributes to energy production in glioma cells. Secondly, we highlight processes (including the Randle Effect, AMPK signaling, mTOR activation, etc.) which are understood to link bio-energetic pathways with oncogenic signals, thereby allowing the glioma cell to achieve a pro-malignant state.

Keywords: autophagy; biosynthesis; brain tumors; cancer; catabolism; glioma; metabolism; mitochondria

References

  1. Cell Death Dis. 2012 Jan 12;3:e248 - PubMed
  2. Am J Cancer Res. 2015 Feb 15;5(3):928-44 - PubMed
  3. Acta Neurochir (Wien). 2012 Aug;154(8):1361-70; discussion 1370 - PubMed
  4. Front Neurosci. 2016 Apr 18;10:156 - PubMed
  5. Biochem Soc Trans. 2002 Nov;30(Pt 6):1064-70 - PubMed
  6. Mol Cell. 2005 Apr 29;18(3):283-93 - PubMed
  7. CNS Oncol. 2012 Sep;1(1):7-10 - PubMed
  8. Sci Transl Med. 2016 Aug 31;8(354):354re3 - PubMed
  9. Neuro Oncol. 2016 Sep;18(9):1219-29 - PubMed
  10. J Neurooncol. 2014 Jun;118(2):277-87 - PubMed
  11. Science. 1956 Aug 10;124(3215):269-70 - PubMed
  12. Mol Cell. 2010 Mar 12;37(5):620-32 - PubMed
  13. PLoS One. 2015 Jun 08;10(6):e0129802 - PubMed
  14. Oncogene. 2017 May 11;36(19):2637-2642 - PubMed
  15. Cancer Cell. 2007 Jan;11(1):37-51 - PubMed
  16. PLoS One. 2015 Jun 17;10 (6):e0130357 - PubMed
  17. J Transl Med. 2014 Apr 29;12:107 - PubMed
  18. J Clin Neurosci. 2013 May;20(5):717-20 - PubMed
  19. Front Immunol. 2016 Apr 26;7:156 - PubMed
  20. Mol Cell Biol. 2015 Jan;35(1):182-98 - PubMed
  21. Oncotarget. 2016 Oct 18;7(42):67966-67985 - PubMed
  22. Int J Mol Sci. 2016 Jun 22;17 (6): - PubMed
  23. Oncogene. 2012 Aug 16;31(33):3764-76 - PubMed
  24. J BUON. 2011 Jul-Sep;16(3):409-13 - PubMed
  25. BMC Cancer. 2016 May 13;16:310 - PubMed
  26. J Neurooncol. 2015 May;123(1):35-42 - PubMed
  27. Nat Genet. 1994 Oct;8(2):171-6 - PubMed
  28. Neuro Oncol. 2015 Jan;17(1):95-106 - PubMed
  29. Science. 2001 Nov 2;294(5544):1102-5 - PubMed
  30. Mol Cell. 2001 Aug;8(2):317-25 - PubMed
  31. Cell. 2010 Apr 16;141(2):280-9 - PubMed
  32. PLoS One. 2012;7(9):e45319 - PubMed
  33. Nat Rev Cancer. 2011 Feb;11(2):85-95 - PubMed
  34. Exp Biol Med (Maywood). 2004 Jul;229(7):567-85 - PubMed
  35. Neuro Oncol. 2015 Jul;17(7):942-52 - PubMed
  36. J Electron Microsc (Tokyo). 2008 Jan;57(1):33-9 - PubMed
  37. Exp Cell Res. 2001 Oct 15;270(1):66-77 - PubMed
  38. Acta Physiol (Oxf). 2009 May;196(1):3-14 - PubMed
  39. Acta Pharmacol Sin. 2014 Dec;35(12):1556-65 - PubMed
  40. Tumour Biol. 2015 May;36(5):3823-9 - PubMed
  41. Neuro Oncol. 2010 Aug;12(8):882-9 - PubMed
  42. Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):251-62 - PubMed
  43. Cell Death Differ. 2009 May;16(5):738-48 - PubMed
  44. Gene. 2016 Jan 10;575(2 Pt 1):187-90 - PubMed
  45. Prostaglandins Leukot Essent Fatty Acids. 2002 Nov;67(5):283-92 - PubMed
  46. Nat Rev Mol Cell Biol. 2014 Oct;15(10):634-46 - PubMed
  47. Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2310-5 - PubMed
  48. Nat Commun. 2015 Nov 02;6:8784 - PubMed
  49. Crit Rev Biochem Mol Biol. 2015;50(3):242-55 - PubMed
  50. J Carcinog. 2006 May 11;5:14 - PubMed
  51. Mol Cancer Res. 2015 Jul;13(7):1059-72 - PubMed
  52. Oncotarget. 2015 Aug 28;6(25):21301-14 - PubMed
  53. Biochim Biophys Acta. 2008 Sep;1777(9):1092-7 - PubMed
  54. Oncogenesis. 2016 May 30;5(5):e227 - PubMed
  55. Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14217-22 - PubMed
  56. Science. 2005 Feb 18;307(5712):1098-101 - PubMed
  57. Cell Death Differ. 2016 Dec;23 (12 ):2007-2018 - PubMed
  58. Neuro Oncol. 2012 Aug;14(8):979-93 - PubMed
  59. Cell Cycle. 2010 Jan 15;9(2):211-2 - PubMed
  60. Mol Cell Biol. 1999 Jan;19(1):1-11 - PubMed
  61. Cell Cycle. 2012 Jul 15;11(14 ):2660-71 - PubMed
  62. Nature. 2008 Mar 13;452(7184):230-3 - PubMed
  63. PLoS Genet. 2009 Feb;5(2):e1000374 - PubMed
  64. Cell. 2009 May 1;137(3):413-31 - PubMed
  65. Curr Opin Genet Dev. 2014 Feb;24:46-51 - PubMed
  66. Curr Neurol Neurosci Rep. 2016 Feb;16(2):17 - PubMed
  67. Science. 2010 Dec 3;330(6009):1340-4 - PubMed
  68. J Neurooncol. 2014 Jun;118(2):247-56 - PubMed
  69. Biochem Pharmacol. 2009 Jun 1;77(11):1684-93 - PubMed
  70. Autophagy. 2011 Jan;7(1):40-50 - PubMed
  71. Sci Signal. 2009 Jan 27;2(55):ra4 - PubMed
  72. Nat Cell Biol. 2011 May;13(5):589-98 - PubMed
  73. Stem Cells. 2015 Jul;33(7):2306-19 - PubMed
  74. PLoS One. 2014 Sep 22;9(9):e108289 - PubMed
  75. PLoS One. 2011;6(5):e19868 - PubMed
  76. Neuro Oncol. 2012 Nov;14 Suppl 5:v1-49 - PubMed
  77. Proc Natl Acad Sci U S A. 2012 Apr 3;109 (14 ):5316-21 - PubMed
  78. Biochim Biophys Acta. 2012 Oct;1817(10):1833-8 - PubMed
  79. Cell Rep. 2014 Oct 9;9(1):349-65 - PubMed
  80. Biochem Soc Trans. 2003 Dec;31(Pt 6):1143-51 - PubMed
  81. J Neurosci Methods. 2009 Jan 30;176(2):192-9 - PubMed
  82. J Radiat Res. 2007 Jul;48(4):317-25 - PubMed
  83. Oncogene. 2015 Jul;34(29):3848-59 - PubMed
  84. Cell Stem Cell. 2009 Jun 5;4(6):568-80 - PubMed
  85. Oncotarget. 2016 Mar 22;7(12):15200-14 - PubMed
  86. Clin Sci (Lond). 2013 Feb;124(3):153-64 - PubMed
  87. Oncogene. 2013 Feb 7;32(6):699-712 - PubMed
  88. J Biol Chem. 2007 Apr 13;282(15):11521-9 - PubMed
  89. Cell Metab. 2013 Nov 5;18(5):726-39 - PubMed
  90. Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19611-6 - PubMed
  91. PLoS One. 2015 Jan 29;10(1):e0116740 - PubMed
  92. J Neuropathol Exp Neurol. 2005 Jun;64(6):479-89 - PubMed
  93. Cell Metab. 2016 Aug 9;24(2):311-23 - PubMed
  94. Cell Metab. 2012 Jun 6;15(6):827-37 - PubMed
  95. Biochem J. 2002 May 15;364(Pt 1):309-15 - PubMed
  96. Oncotarget. 2017 Feb 28;8(9):14860-14875 - PubMed
  97. Oncology. 2007;73(1-2):21-5 - PubMed
  98. Cancer Discov. 2014 Dec;4(12 ):1406-17 - PubMed
  99. Antioxid Redox Signal. 2012 May 15;16(10):1150-80 - PubMed
  100. PLoS Genet. 2014 Sep 18;10(9):e1004620 - PubMed
  101. Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):E4214-23 - PubMed
  102. Cell Death Dis. 2016 May 05;7:e2213 - PubMed
  103. Neurobiol Dis. 2010 Jan;37(1):118-29 - PubMed
  104. Cancer Res. 1999 Aug 15;59(16):3915-8 - PubMed
  105. PLoS One. 2013 Nov 18;8(11):e80397 - PubMed
  106. Cancer Med. 2014 Aug;3(4):812-24 - PubMed
  107. Cancer Cell. 2006 May;9(5):391-403 - PubMed
  108. Neuro Oncol. 2015 Jun;17 (6):843-53 - PubMed
  109. Cancer Chemother Pharmacol. 2013 Apr;71(4):929-36 - PubMed
  110. Oncologist. 2007 Dec;12 (12 ):1395-403 - PubMed
  111. Neuro Oncol. 2016 Sep;18(9):1199-208 - PubMed
  112. Glia. 2014 Apr;62(4):514-25 - PubMed
  113. Stem Cells Transl Med. 2012 Nov;1(11):811-24 - PubMed
  114. Pharmacol Res. 2012 Jan;65(1):111-9 - PubMed
  115. Nat Commun. 2016 Dec 14;7:13666 - PubMed
  116. Eur J Cancer. 2014 Dec;50(18):3187-97 - PubMed
  117. Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):985-90 - PubMed
  118. Cell. 2006 Jul 14;126(1):107-20 - PubMed
  119. Cancer Res. 1997 Oct 1;57(19):4242-8 - PubMed
  120. Cell Mol Life Sci. 2007 May;64(10):1290-302 - PubMed
  121. PLoS Comput Biol. 2015 Apr 17;11(4):e1004169 - PubMed
  122. Nature. 2012 May 09;485(7400):661-5 - PubMed
  123. Nature. 2013 Sep 19;501(7467):373-9 - PubMed
  124. Free Radic Biol Med. 2005 Jan 1;38(1):12-23 - PubMed
  125. J Biol Chem. 2005 Nov 25;280(47):39505-9 - PubMed
  126. J Biol Chem. 1997 Sep 5;272(36):22776-80 - PubMed
  127. J Cell Mol Med. 2013 Jan;17 (1):30-54 - PubMed
  128. Lancet. 1963 Apr 13;1(7285):785-9 - PubMed
  129. Acta Neuropathol. 2012 Apr;123(4):587-600 - PubMed
  130. Science. 2004 Apr 23;304(5670):596-600 - PubMed
  131. Oncogene. 2006 Aug 7;25(34):4675-82 - PubMed
  132. Acta Neuropathol. 2013 Nov;126(5):763-80 - PubMed
  133. Cell Rep. 2014 May 22;7(4):1248-58 - PubMed
  134. PLoS One. 2015 Apr 13;10 (4):e0123721 - PubMed
  135. Nature. 2008 Oct 23;455(7216):1061-8 - PubMed
  136. Sci Transl Med. 2015 Feb 11;7(274):274ra17 - PubMed
  137. Cancer Cell. 2007 Apr;11(4):335-47 - PubMed
  138. J Biol Chem. 2011 Sep 16;286(37):32843-53 - PubMed
  139. Oncotarget. 2016 Nov 15;7(46):76238-76249 - PubMed
  140. BMC Biol. 2013 Apr 15;11:36 - PubMed
  141. Gene. 2004 Aug 4;337:1-13 - PubMed
  142. Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21660-5 - PubMed
  143. Mol Oncol. 2015 Oct;9(8):1612-25 - PubMed
  144. FEBS Lett. 2011 Apr 6;585(7):952-7 - PubMed
  145. Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10190-5 - PubMed
  146. Mol Cancer. 2004 Jul 12;3:19 - PubMed
  147. Nature. 2015 Apr 16;520(7547):363-7 - PubMed
  148. Oncogene. 2015 Oct 1;34(40):5128-40 - PubMed
  149. Oncotarget. 2015 Sep 22;6(28):26119-28 - PubMed
  150. Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):8012-7 - PubMed
  151. Nucl Med Rev Cent East Eur. 2002;5(2):127-30 - PubMed
  152. Cell Metab. 2013 Aug 6;18(2):153-61 - PubMed
  153. Nat Cell Biol. 2007 Feb;9(2):218-24 - PubMed
  154. Nat Struct Mol Biol. 2008 Sep;15(9):924-31 - PubMed
  155. Cell Death Dis. 2014 May 08;5:e1212 - PubMed
  156. Oncotarget. 2016 Dec 20;7(51):84623-84633 - PubMed
  157. EMBO J. 2009 Jun 3;28(11):1589-600 - PubMed
  158. Genes Dev. 2011 Sep 15;25(18):1895-908 - PubMed
  159. Neuro Oncol. 2015 Sep;17(9):1220-30 - PubMed
  160. Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7455-60 - PubMed
  161. Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):102-14 - PubMed
  162. Oncogene. 2005 Jun 16;24(26):4165-73 - PubMed
  163. Cancer Res. 2001 Mar 1;61(5):1957-63 - PubMed
  164. Nutr Metab (Lond). 2010 Sep 10;7:74 - PubMed
  165. Cell. 2012 Apr 13;149(2):274-93 - PubMed
  166. Cell Death Differ. 2012 Feb;19(2):284-94 - PubMed
  167. Cell Death Differ. 2012 Jun;19(6):968-79 - PubMed
  168. EMBO Rep. 2002 May;3(5):420-5 - PubMed
  169. Cancer Res. 2001 Aug 1;61(15):5843-9 - PubMed
  170. Science. 2007 Oct 12;318(5848):287-90 - PubMed
  171. Exp Cell Res. 2017 Jan 1;350(1):32-40 - PubMed
  172. Neurochem Int. 2015 Nov;90:98-106 - PubMed
  173. Mol Cell. 2014 Jul 17;55(2):253-63 - PubMed
  174. Nat Rev Drug Discov. 2008 Oct;7(10):841-53 - PubMed
  175. J Nucl Med. 2005 Jun;46(6):945-52 - PubMed
  176. Mol Cancer Ther. 2014 Mar;13(3):596-605 - PubMed
  177. Neuro Oncol. 2016 Jan;18(1):16-26 - PubMed
  178. Nat Cell Biol. 2011 Mar;13(3):310-6 - PubMed
  179. Cancer Res. 2007 Jul 15;67(14):6745-52 - PubMed
  180. PLoS One. 2014 Oct 31;9(10):e109916 - PubMed
  181. Cell. 2014 Dec 18;159(7):1603-14 - PubMed
  182. Stem Cell Res Ther. 2015 Oct 15;6:198 - PubMed
  183. Science. 2009 May 22;324(5930):1029-33 - PubMed
  184. Glia. 2006 May;53(7):733-43 - PubMed
  185. Clin Cancer Res. 2016 Jul 15;22(14):3513-23 - PubMed
  186. Cell Signal. 2011 Nov;23 (11):1869-75 - PubMed
  187. Int J Cell Biol. 2012;2012:161837 - PubMed
  188. Brain Pathol. 2015 Nov;25(6):755-9 - PubMed
  189. Nucleic Acids Res. 2013 Jan;41(Database issue):D920-4 - PubMed
  190. Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16062-7 - PubMed
  191. Cell Cycle. 2008 Jun 15;7(12):1782-7 - PubMed
  192. Sci Transl Med. 2010 May 12;2(31):31ra34 - PubMed
  193. Science. 2006 Jun 16;312(5780):1650-3 - PubMed
  194. Cell Rep. 2013 May 30;3(5):1440-8 - PubMed
  195. Curr Opin Genet Dev. 2010 Feb;20(1):51-6 - PubMed
  196. J Med Genet. 2000 Jun;37(6):410-4 - PubMed
  197. Br J Cancer. 1996 Sep;74(6):839-45 - PubMed
  198. Tumour Biol. 2015 Sep;36(10 ):7699-710 - PubMed
  199. Oncogene. 2007 Mar 22;26(13):1840-51 - PubMed
  200. Int J Biochem Cell Biol. 2015 Jun;63:46-54 - PubMed
  201. PLoS One. 2012;7(5):e36197 - PubMed
  202. J Biol Chem. 2012 Jun 8;287(24):20164-75 - PubMed
  203. Annu Rev Biochem. 2008;77:289-312 - PubMed
  204. PLoS One. 2013 Dec 13;8(12 ):e83318 - PubMed
  205. Mol Cancer. 2008 May 12;7:37 - PubMed
  206. Nat Med. 2013 Jul;19(7):901-8 - PubMed
  207. Cell Death Differ. 2003 Aug;10(8):870-80 - PubMed
  208. J Biol Chem. 2000 Aug 18;275(33):25130-8 - PubMed
  209. Tumour Biol. 2016 May;37(5):6761-8 - PubMed
  210. Curr Opin Genet Dev. 2008 Feb;18(1):54-61 - PubMed
  211. Cell Death Differ. 2004 Aug;11(8):853-61 - PubMed
  212. Cancer Cell. 2015 Feb 9;27(2):257-70 - PubMed
  213. Cancer Cell. 2010 Jan 19;17(1):98-110 - PubMed
  214. Cancer Res. 2005 Jan 1;65(1):177-85 - PubMed
  215. Front Oncol. 2014 Mar 14;4:52 - PubMed
  216. PLoS One. 2014 Jan 08;9(1):e84931 - PubMed
  217. J Biol Chem. 2010 Dec 24;285(52):40461-71 - PubMed
  218. Amino Acids. 2012 Jul;43(1):355-63 - PubMed
  219. Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1059-64 - PubMed
  220. Cell Death Dis. 2015 Oct 15;6:e1909 - PubMed
  221. J Neurosurg. 2006 Jul;105(1):111-8 - PubMed
  222. Mol Cancer. 2006 Mar 28;5:13 - PubMed
  223. Nat Med. 2011 Sep 11;17(10):1269-74 - PubMed
  224. Cell Death Differ. 2013 Dec;20(12):1644-53 - PubMed
  225. Cell. 2008 Aug 8;134(3):451-60 - PubMed
  226. Pediatr Res. 1997 Oct;42(4):498-502 - PubMed
  227. J Clin Invest. 2015 Apr;125(4):1591-602 - PubMed
  228. NMR Biomed. 2012 Nov;25(11):1234-44 - PubMed
  229. Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7461-6 - PubMed
  230. Cancer Res. 2016 Oct 1;76(19):5845-5856 - PubMed
  231. Nat Neurosci. 2015 Apr;18(4):501-10 - PubMed
  232. J Biol Chem. 2012 Sep 28;287(40):33436-46 - PubMed
  233. Cancer Res. 1993 Jun 15;53(12 ):2736-9 - PubMed
  234. Mol Cell. 2011 Dec 23;44(6):878-92 - PubMed
  235. Neuro Oncol. 2017 Jan;19(1):43-54 - PubMed
  236. Cancer Res. 2009 Oct 15;69(20):7986-93 - PubMed
  237. Cancer Res. 2015 Aug 1;75(15):2999-3009 - PubMed
  238. Mol Cell. 2016 Jan 21;61(2):210-21 - PubMed
  239. PLoS One. 2012;7(10):e47010 - PubMed
  240. Cancer Res. 2013 Apr 15;73(8):2628-38 - PubMed

Publication Types